Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Medical treatment of vestibular disorders
Expert Opinion in Pharmacotherapy, 06/19/09
Brandt T et al. - In vestibular neuritis, recovery of the peripheral vestibular function can be improved by oral corticosteroids; in Meniere's disease, there is first evidence that high-dose, long-term administration of betahistine reduces attack frequency; carbamazepine or oxcarbamazepine is the treatment of first choice in vestibular paroxysmia, a disorder mainly caused by neurovascular cross-compression; the potassium channel blocker aminopyridine provides a new therapeutic principle for treatment of downbeat nystagmus, upbeat nystagmus, and episodic ataxia type 2.
Related Articles
Bilateral Vestibulopathy: Clinical, Diagnostic, and Genetic Considerations
Seminars in Neurology, 11/02/09
Relevance Score: 67%
Vertigo Presentations in the Emergency Department
Seminars in Neurology, 10/28/09
Relevance Score: 67%
Anatomical and Physiological Considerations in Vestibular Dysfunction and Compensation
Seminars in Hearing, 10/26/09
Relevance Score: 67%
Vestibular Neuritis
Seminars in Neurology, 10/30/09
Relevance Score: 66%
Imbalance and Vertigo: The Aging Human Vestibular Periphery
Seminars in Neurology, 10/28/09
Relevance Score: 66%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Temporal Reduction of HIV Type 1 Viral Load in Breast Milk by Single-Dose Nevirapine during Prevention of MTCT
AIDS Research and Human Retroviruses, 12/18/09
Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome
European Journal of Pain, 12/18/09
Low levels of steroid-metabolizing hepatic enzyme activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose
Journal of Orthopaedic Science, 12/18/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases
Current Medical Research and Opinion, 12/18/09
Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
Clinical Interventions in Aging, 12/18/09
Iron supplementation in the non-dialysis chronic kidney disease patient: oral or intravenous
Current Medical Research and Opinion, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


